The 3rd IMPACCT Real World Evidence Summit Europe is the only industry meeting dedicated to uniting experts in RWE, Evidence Generation, and Medical Affairs to consolidate, innovate and apply RWE across the drug development lifecycle, from external control arms to reimbursement.
With a tight focus on leveraging AI for big data analysis, accessing standardised and high-quality datasets, and creating a robust integrated evidence strategy, join 50+ industry pioneers from AstraZeneca, Pfizer, Novartis, Boehringer Ingelheim and more to collaboratively establish best practice and bridge the evidence gap between clinical research and practice.
